Genotype-dependent cooperation of ionizing radiation with BRAF inhibition in BRAF V600E-mutated carcinomasDASGUPTA, Tina; HAAS-KOGAN, Daphne A; XIAODONG YANG et al.Investigational new drugs. 2013, Vol 31, Num 5, pp 1136-1141, issn 0167-6997, 6 p.Article

Clinical Significance of BRAF Gene Mutations in Patients with Non-small Cell Lung CancerKOBAYASHI, Masashi; SONOBE, Makoto; TAKAHASHI, Tsuyoshi et al.Anticancer research. 2011, Vol 31, Num 12, pp 4619-4623, issn 0250-7005, 5 p.Article

BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naeviNGUYEN, L. P; EMLEY, A; WAJAPEYEE, N et al.British journal of dermatology (1951). 2010, Vol 162, Num 3, pp 677-680, issn 0007-0963, 4 p.Article

BRAF^V600E protein expression and outcome from BRAF inhibitor treatment in BRAF^V600E metastatic melanomaWILMOTT, J. S; MENZIES, A. M; LONG, G. V et al.British journal of cancer. 2013, Vol 108, Num 4, pp 924-931, issn 0007-0920, 8 p.Article

The Association of the BRAF^V600E Mutation With Prognostic Factors and Poor Clinical Outcome in Papillary Thyroid Cancer: A Meta-AnalysisTAE HYUK KIM; YOUNG JOO PARK; BO YOUN CHO et al.Cancer. 2012, Vol 118, Num 7, pp 1764-1773, issn 0008-543X, 10 p.Article

BRAF inhibitor activity in V600R metastatic melanomaKLEIN, Oliver; CLEMENTS, Arthur; MENZIES, Alexander M et al.European journal of cancer (1990). 2013, Vol 49, Num 5, pp 1073-1079, issn 0959-8049, 7 p.Article

Atypical Teratoid/Rhabdoid Tumor Arising in a Ganglioglioma: Genetic CharacterizationKLEINSCHMIDT-DEMASTERS, B. K; BIRKS, Diane K; AISNER, Dara L et al.The American journal of surgical pathology. 2011, Vol 35, Num 12, pp 1894-1901, issn 0147-5185, 8 p.Article

Molecular Diagnostics of Melanoma Fine-Needle Aspirates: A Cytology-Histology Correlation StudyBERNACKI, Kurt D; BETZ, Bryan L; WEIGELIN, Helmut C et al.American journal of clinical pathology. 2012, Vol 138, Num 5, pp 670-677, issn 0002-9173, 8 p.Article

Identification of amidoheteroaryls as potent inhibitors of mutant (V600E) B-Raf kinase with in vivo activityLYNE, Paul D; AQUILA, Brian; BLOCK, Michael H et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 3, pp 1026-1029, issn 0960-894X, 4 p.Article

Potent and selective pyrazole-based inhibitors of B-Raf kinaseHANSEN, Joshua D; GRINA, Jonas; BRANDHUBER, Barbara J et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 16, pp 4692-4695, issn 0960-894X, 4 p.Article

The Histopathology of BRAF-V600E-mutated Lung AdenocarcinomaYOUSEM, Samuel A; NIKIFOROVA, Marina; NIKIFOROV, Yuri et al.The American journal of surgical pathology. 2008, Vol 32, Num 9, pp 1317-1321, issn 0147-5185, 5 p.Article

Highly conserved sequence of exon 15 BRAF gene and KRAS codon 12 mutation among Greek patients with colorectal cancerSYMVOULAKIS, E. K; ZARAVINOS, A; PANUTSOPULOS, D et al.The International journal of biological markers. 2007, Vol 22, Num 1, pp 12-18, issn 0393-6155, 7 p.Article

Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)GOLDSTEIN, J; TRAN, B; DESAI, J et al.Annals of oncology. 2014, Vol 25, Num 5, pp 1032-1038, issn 0923-7534, 7 p.Article

Dabrafénib et tramétinib pour traiter le mélanome métastatique = Dabrafenib and trametinib for metastatic melanomaThe Medical letter on drugs and therapeutics (Edition française). 2013, Vol 35, Num 18, pp 70-71, issn 0253-8512, 2 p.Article

Dabrafenib: First Global ApprovalBALLANTYNE, Anita D; GARNOCK-JONES, Karly P.Drugs (Basel). 2013, Vol 73, Num 12, pp 1367-1376, issn 0012-6667, 10 p.Article

Sensitive electrochemical analysis of BRAF V600E mutation based on an amplification-refractory mutation system coupled with multienzyme functionalized Fe₃O_4/Au nanoparticlesBO SITU; NANNAN CAO; LEI ZHENG et al.Biosensors & bioelectronics. 2013, Vol 43, pp 257-263, issn 0956-5663, 7 p.Article

Sorafenib in advanced melanoma : a Phase II randomised discontinuation trial analysisEISEN, T; AHMAD, T; NATHANSON, K. L et al.British journal of cancer. 2006, Vol 95, Num 5, pp 581-586, issn 0007-0920, 6 p.Article

Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenibFOLLOWS, George A; SIMS, Hannah; BLOXHAM, David M et al.British journal of haematology. 2013, Vol 161, Num 1, pp 150-153, issn 0007-1048, 4 p.Article

Targeting the MAPK pathway in melanoma: Why some approaches succeed and other failINAMDAR, Gajanan S; MADHUNAPANTULA, Subbarao V; ROBERTSON, Gavin P et al.Biochemical pharmacology. 2010, Vol 80, Num 5, pp 624-637, issn 0006-2952, 14 p.Article

Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disordersBLOMBERY, Piers A; WONG, Stephen Q; HEWITT, Chelsee A et al.Haematologica (Roma). 2012, Vol 97, Num 5, pp 780-783, issn 0390-6078, 4 p.Article

Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumabSHAHABI, Vafa; WHITNEY, Gena; HAMID, Omid et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 5, pp 733-737, issn 0340-7004, 5 p.Article

Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesisBOSSARD, Celine; DENIS, Marc G; BEZIEAU, Stephane et al.Oncology reports. 2007, Vol 18, Num 5, pp 1093-1097, issn 1021-335X, 5 p.Article

L'essentiel sur...: Zelboraf^® (vemurafenib) = Essentially: Zelboraf^® (vemurafenib)REY, Jean-Baptiste.Journal de pharmacie clinique (Paris). 2013, Vol 32, Num 3, issn 0291-1981, p. 192Article

Mutation BRAF V600E et carcinomes papillaires de la thyroïde: prévalence et faisabilité de la détection sur produits de cytoponction = BRAF V600E mutation in papillary thyroid carcinoma: Prevalence and detection in fine needle aspiration specimensDUJARDIN, Fanny; PAGES, Jean-Christophe; COLLIN, Christine et al.Annales de pathologie (Print). 2010, Vol 30, Num 4, pp 252-262, issn 0242-6498, 11 p.Article

Usefulness of immunohistochemistry for the detection of the BRAF V600E mutation in Japanese lung adenocarcinomaSASAKI, Hidefumi; SHIMIZU, Shigeki; TANI, Yoichi et al.Lung cancer. 2013, Vol 82, Num 1, pp 51-54, issn 0169-5002, 4 p.Article